Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematology
•
Infectious Disease
•
Allergy & Immunology
•
Dermatology
•
Internal Medicine
What is your diagnostic approach to mild, chronic eosinophilia with AEC <1500?
When would a patient qualify for anti-IL5 therapy?
How to choose between IL-4, IL-5, or IL-13?
Related Questions
In light of recent measles outbreaks in the US, would you recommend an MMR booster for an immunocompetent patients born before 1957?
Do you routinely recommend transition to dual PO antibiotic coverage for strep species and MRSA, for patients with purulent cellulitis and in the absence of culture data?
What is your approach to iron supplementation in patients with an active infection?
Would you supplement iron for low iron studies in absence of anemia?
In patients with iron deficiency due to history of gastric bypass or IBD, would you consider oral iron therapy if the iron deficiency anemia is mild?
How do you counsel patients with minimally symptomatic factor VII deficiency about procedures and periprocedural management?
Excluding CLL, in which patients would you screen for hypogammaglobulinemia?
How soon after stopping oral steroids can patch testing be performed?
Would you still consider omalizumab for CSU with angioedema in a patient with Factor V Leiden deficiency?
Is there any indication for IVIG in immunocompromised patients with only decreased IgM and/or IgA levels?